** Shares of Australia's Neurizon Therapeutics NUZ.AX slump as much as 23.6% to A$0.084, their lowest since late November 2023

** Biotech company secures firm commitments to raise A$7.1 million ($4.73 million) via placement at A$0.08 per share

** Placement price represents 27.3% discount to NUZ's last close

** Co adds funding package, together with existing cash reserves and future R&D tax rebates, will fund participation in the HEALEY ALS Platform Trial

** Around 691,000 shares change hands, nearly 1.8x 30-day average

** NUZ down 48.8% YTD

($1 = 1.5020 Australian dollars)

(Reporting by Keshav Singh Chundawat in Bengaluru)

((Keshav.singhchundawat@thomsonreuters.com))